title: Is there a role for single-agent MEK inhibition in melanoma?
authors.affiliation: Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
authors.forename: Douglas
authors.initials: D
authors.lastname: Johnson
mesh_terms: D000181:Acrylonitrile / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use*; D006801:Humans; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors*; D008545:Melanoma / Q000188:drug therapy*
chemical_list: D000814:Aniline Compounds; C000610759:MEK inhibitor I; D048369:MAP Kinase Kinase 1; D000181:Acrylonitrile